The Development Convergence of Private Health Insurance in Basic Medical Insurance:International Practices and ImplicationsWang Jiayun, Wang Linan, Zhu Bifan1-6
Analysis of the Development Status and Problems of Private Health Insurance in ShanghaiSong Wenhua, Wang Jiayun, Wang Linan7-10,14
Analysis and Suggestions on the Synergistic Development of Private Health Insurance and Public Hospitals:A Case Study of ShanghaiSong Wenhua, Wang Jiayun, Wu Qingyi, Chen Minxing, Wang Linan, Jin Chunlin11-14
The Current Status,Issues,and Policy Recommendations for the Cooperation between Private Health Insurance and the Pharmaceutical Industry:A Case Study of ShanghaiWang Jiayun, Jin Chunlin, Song Wenhua, Wang Linan, Chen Minxing15-19
Study on the Marginal Contribution Approach to DRG Costing by Integrating Policy Norms and Operational ContextsXie Shitang20-25
Hopital's IT Application Architectures for the Value-Based HealthcareWang Wenhui, Zou Xiaoqi, Li Mujiao26-30
The Impact of National Pharmaceutical Centralized Purchase and Continuation Policies on Drug Usage,Prices and CostsWang Haoyang, Han Yue, Xie Jinping, Shao Rong31-37
Discussion on Building a Medical Artificial Intelligence Technology Assessment System Suitable for Chinese National ConditionsWang Ru, He Da, Fu Yuyan38-43
Analysis of Whether Employee Health Insurance Outpatient Co-payments Can"Crowd out"Commercial Health InsuranceJiang Peifeng, Song Zhanjun44-47,53
Study on the Countermeasure of the"Dual-Channel"Management Policy Execution of National Negotiated Drugs Based on the Perspective of Drug Purchasing Selects of Insured Individuals in Designated Retail PharmaciesDu Qixia, Yang Lijie, Xu Aijun48-53
